Literature DB >> 9393531

Carotid artery stents: early and intermediate follow-up with Doppler US.

M L Robbin1, M E Lockhart, T M Weber, J J Vitek, J K Smith, J Yadav, A Mathur, S S Iyer, G S Roubin.   

Abstract

PURPOSE: To determine whether ultrasound (US) is a sensitive follow-up method after placement of a carotid artery stent for the detection of significant stenosis, occlusion, and other complications at early and intermediate follow-up.
MATERIALS AND METHODS: Doppler US examinations were performed after stent placement in 170 carotid arteries in 119 patients with angiographic correlation. Prospective diagnostic US criteria for stenosis were peak-systolic velocity greater than 1.25 m/sec, internal carotid artery (ICA) to common carotid artery (CCA) peak-systolic velocity ratio of greater than or equal to 3:1, and intrastent doubling of peak-systolic velocity. Retrospective criteria for stenosis were also applied: peak-systolic velocity greater than 1.7 m/sec, ICA end-diastolic velocity greater than 0.4 m/sec, ICA/CCA peak-systolic velocity ratio greater than 2.0, and ICA/CCA end-diastolic velocity ratio greater than 2.4.
RESULTS: Eighty-seven immediate and 83 intermediate (average, 7.3 months) follow-up US examinations were performed. Two stent occlusions were detected. One or more prospective US criteria were abnormal in 26 arteries with a stent. One or more retrospective criteria were positive in 47 arteries. Angiography showed corresponding findings, with only one significant stenosis (63%) in the ICA stents. Moderate collapse of a CCA stent was depicted at US.
CONCLUSION: Only one significant recurrent stenosis was detected, and no significant stenoses were missed at US. US successfully depicted carotid artery stent occlusion and a moderate stent collapse. Sensitivity in the detection of intrastent stenosis is promising. Further study to refine US criteria in a study with longer term follow-up is needed owing to the lack of significant recurrent stenosis in the intermediate follow-up group.

Entities:  

Mesh:

Year:  1997        PMID: 9393531     DOI: 10.1148/radiology.205.3.9393531

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  6 in total

1.  Recanalization results after carotid stent placement.

Authors:  Joachim Berkefeld; Bernd Turowski; Andreas Dietz; Heinrich Lanfermann; Matthias Sitzer; Thomas Schmitz-Rixen; Helmuth Steinmetz; Friedhelm E Zanella
Journal:  AJNR Am J Neuroradiol       Date:  2002-01       Impact factor: 3.825

2.  In-stent hypodense area at two weeks following carotid artery stenting predicts neointimal hyperplasia after two years.

Authors:  Kentaro Yamashita; Jouji Kokuzawa; Tatsuya Kuroda; Satoru Murase; Morio Kumagai; Yasuhiko Kaku
Journal:  Neuroradiol J       Date:  2017-08-17

3.  Follow-up study on in-stent thrombosis after carotid stenting using multidetector CT angiography.

Authors:  Hirotaka Watarai; Yasuhiko Kaku; Mikito Yamada; Jouji Kokuzawa; Toshiki Tanaka; Takashi Andoh; Toru Iwama
Journal:  Neuroradiology       Date:  2009-01-27       Impact factor: 2.804

4.  Open-cell versus closed-cell stent design differences in blood flow velocities after carotid stenting.

Authors:  Damon S Pierce; Eric B Rosero; J Gregory Modrall; Beverley Adams-Huet; R James Valentine; G Patrick Clagett; Carlos H Timaran
Journal:  J Vasc Surg       Date:  2009-03       Impact factor: 4.268

5.  Neointimal proliferation within carotid stents is more pronounced in diabetic patients with initial poor glycaemic state.

Authors:  A Willfort-Ehringer; R Ahmadi; A Gessl; M E Gschwandtner; A Haumer; W Lang; E Minar; S Zehetmayer; H Ehringer
Journal:  Diabetologia       Date:  2004-02-18       Impact factor: 10.122

6.  Transcranial doppler sonography is not a valid diagnostic tool for detection of basilar artery stenosis or in-stent restenosis: a retrospective diagnostic study.

Authors:  Woori Koh; Kai Kallenberg; André Karch; Tobias Frank; Michael Knauth; Mathias Bähr; Jan Liman
Journal:  BMC Neurol       Date:  2017-05-11       Impact factor: 2.474

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.